Cargando…
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer
PURPOSE: To determine the ability of RAD51 foci to predict platinum chemotherapy response in high-grade serous ovarian cancer (HGSOC) patient-derived samples. EXPERIMENTAL DESIGN: RAD51 and γH2AX nuclear foci were evaluated by immunofluorescence in HGSOC patient-derived cell lines (n = 5), organoids...
Autores principales: | Compadre, Amanda J., van Biljon, Lillian N., Valentine, Mark C., Llop-Guevara, Alba, Graham, Emily, Fashemi, Bisiayo, Herencia-Ropero, Andrea, Kotnik, Emilee N., Cooper, Isaac, Harrington, Shariska P., Kuroki, Lindsay M., McCourt, Carolyn K., Hagemann, Andrea R., Thaker, Premal H., Mutch, David G., Powell, Matthew A., Sun, Lulu, Mosammaparast, Nima, Serra, Violeta, Zhao, Peinan, Lomonosova, Elena, Khabele, Dineo, Mullen, Mary M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320470/ https://www.ncbi.nlm.nih.gov/pubmed/37097615 http://dx.doi.org/10.1158/1078-0432.CCR-22-3335 |
Ejemplares similares
-
Persistent inequities in access to and continuity of gynecologic oncology care during the COVID-19 pandemic (052)
por: Bruce, Shaina, et al.
Publicado: (2022) -
Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer
por: Toboni, Michael D., et al.
Publicado: (2021) -
Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care
por: Bruce, Shaina F., et al.
Publicado: (2022) -
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival
por: Kotnik, Emilee N., et al.
Publicado: (2023) -
Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery
por: Zamorano, Abigail S., et al.
Publicado: (2022)